-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Altimmune, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
- Altimmune, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$24.8M, a 9.88% decline year-over-year.
- Altimmune, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$112M, a 31.1% decline year-over-year.
- Altimmune, Inc. annual Operating Income (Loss) for 2023 was -$95.9M, a 9.33% decline from 2022.
- Altimmune, Inc. annual Operating Income (Loss) for 2022 was -$87.7M, a 9.47% increase from 2021.
- Altimmune, Inc. annual Operating Income (Loss) for 2021 was -$96.9M, a 76.9% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)